Found: 10
Select item for more details and to access through your institution.
Current management of succinate dehydrogenase–deficient gastrointestinal stromal tumors.
- Published in:
- Cancer & Metastasis Reviews, 2019, v. 38, n. 3, p. 525, doi. 10.1007/s10555-019-09818-0
- By:
- Publication type:
- Article
Commission on Cancer Facility Type is Associated with Overall Survival in Patients with Gastric Adenocarcinoma in the United States.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 5, p. 2846, doi. 10.1245/s10434-020-09422-5
- By:
- Publication type:
- Article
Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
- Published in:
- Journal of Surgical Oncology, 2019, v. 120, n. 4, p. 715, doi. 10.1002/jso.25621
- By:
- Publication type:
- Article
Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-68964-6
- By:
- Publication type:
- Article
Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 3, p. 702, doi. 10.1002/ijc.33230
- By:
- Publication type:
- Article
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.
- Published in:
- Journal of Translational Medicine, 2016, v. 14, p. 1, doi. 10.1186/s12967-016-1075-6
- By:
- Publication type:
- Article
Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 17, p. 2960, doi. 10.1002/cncr.29434
- By:
- Publication type:
- Article
Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. e908, doi. 10.1093/oncolo/oyac189
- By:
- Publication type:
- Article
A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article